All News

See how pharmacists turn pharmacogenomic results into safer prescribing—overcoming reimbursement, EHR, and equity barriers to scale testing in community pharmacies.

Phase 3 findings from the VIKTORIA-1 trial demonstrated clinically meaningful progression-free survival improvements with gedatolisib-based regimens in patients with PIK3CA-mutant HR+/HER2– advanced breast cancer.

Metabolic dysfunction-associated steatotic liver disease (MASLD) remains largely underdiagnosed and asymptomatic, creating major opportunities for pharmacists to drive early identification, lifestyle intervention, and metabolic risk management.

This approval marks the first high-efficacy B-cell depletion therapy approved for pediatric patients 10 years and older.

Treatment with zenocutuzumab-zbco led to an overall response rate of 36.8% for a duration ranging from 2.8 to 12.9 months.

FDA approval brings AstraZeneca’s Breztri Aerosphere triple asthma inhaler for patients 12 years and older, boosting lung function fast and simplifying daily control.

Pharmacists are vital in identifying at-risk patients, supporting diagnostic testing, optimizing therapy, and monitoring medication adjustments.

Pharmacy technicians are increasingly central to obesity care, supporting medication access, workflow efficiency, and patient engagement in ambulatory settings.

New findings reveal that mouse liver cells can form the viral template behind chronic HBV infection.

This review examines evidence on changes in muscle mass with incretin-based therapies and focuses on current and emerging strategies to preserve and enhance skeletal muscle mass.

Psilocybin-assisted psychotherapy significantly increased cocaine abstinence rates and reduced relapse risk in patients with cocaine use disorder.

Education is shifting from memorization of drug information to mastery of digital health, interprofessional collaboration, and demonstrated clinical competency.

A recent report of liver failure in a patient receiving orforglipron has renewed attention on the long-term safety monitoring of GLP-1 receptor agonists.

Technician-led strategies are accelerating antiretroviral therapy access and improving long-term adherence for patients with HIV.

Explore updates around hantavirus outbreak and FDA controversies.

Forrest N. Ridgway, PharmD, BCOP, discusses health misinformation, AI-generated medical advice, wellness culture, and the controversial therapies patients are bringing into the clinic.

Effective real-world management of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) is critical to safely delivering CAR T-cell therapies and bispecific antibodies.

Advanced lung cancer inflammation index (ALI) predicts 3‑month recovery after thrombolysis for acute ischemic stroke, with low ALI signaling higher risk.

University of Arizona pharmacy interns who received mentorship and engaged in pharmacist-level tasks report greater satisfaction and perceived professional readiness, highlighting a need to restructure internships as longitudinal, competency-based experiences.

Joseph Saseen, PharmD; and Joel C. Marrs, PharmD, discuss key updates in the 2026 dyslipidemia guidelines and their implications for clinical and pharmacy practice.

Some pharmacists are exploring the possibilities of moving to New Zealand for better work/life balance.

A new study describes the high symptom burden carried by pediatric long COVID patients and highlights integrative medicine's role in their care.

GLP-1 weight-loss drugs reshape healthcare and consumer spending, as markets surge, coverage splits, and subscription models spread.

FDA expands teplizumab to age 1 year for stage 2 type 1 diabetes—pharmacists must learn dosing, infusion logistics, and safety monitoring.

In this debut episode Erica Marini and her colleagues discuss the critical role pharmacists play in complex neurologic care and the latest emerging therapies and research presented at the AAN 2026 Annual Meeting.

The World Health Organization confirmed the outbreak is the Andes strain, the only known human transmissible hantavirus.

The agency greenlit 4 Glas electronic nicotine delivery systems through the premarket tobacco product application pathway, a historic first that comes amid reported White House pressure on FDA Commissioner Marty Makary.

FDA leaders reportedly delay vaccine safety findings on COVID-19 and shingles shots, raising transparency concerns and new challenges for pharmacists.